A Brief Introduction to Current Cancer Gene Therapy

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Gene therapy emerged in the late 1980s as a novel therapeutic approach for genetic diseases.
• It has since been adapted for malignant diseases, becoming a major focus in cancer research and treatment.
• Cancer gene therapy constitutes the largest proportion of gene therapy research and clinical trials globally.

Purpose of the Study:

• To provide an overview of current key developments in cancer gene therapy.
• To highlight recent research directions and clinical applications in the field.
• To synthesize advancements in vector design, gene targeting, and immunogene therapies for cancer.

Main Methods:

• Review of accumulated knowledge and advancements in cancer gene therapy over decades.
• Analysis of improvements in vector design and transgene repertoire.
• Inclusion of novel gene therapeutic technologies like CRISPR/Cas and sleeping beauty vectors.

Main Results:

• Significant improvements in vector design and transgene delivery systems.
• Development of more targeted interventions for cancer treatment.
• Emergence of effective cancer immunogene therapies and integration of new technologies.

Conclusions:

• Cancer gene therapy has made substantial progress, translating into numerous clinical trials.
• Ongoing innovations in technology and strategy continue to drive the field forward.
• The field is poised for further advancements in improving outcomes for cancer patients.